QOL-48. SEIZURE IN PEDIATRIC PATIENTS WITH BRAIN TUMORS

Viviane Robert‐Boire, Sébastien Perreault(Centre Hospitalier Universitaire Sainte-Justine), Béatrice Desnous(Inserm), Alexander G. Weil(McGill University)

Neuro-Oncology

June 1, 2018

10.1093/neuonc/noy059.630

Cited by 0

Related Papers

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

|The Lancet Oncology|2013|404

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

|The Lancet Oncology|2016|369

Diagnosis delay in West syndrome: misdiagnosis and consequences

|European Journal of Pediatrics|2012|88

Molecular and clinical descriptions of patients with <scp>GABA<sub>A</sub></scp> receptor gene variants (<i><scp>GABRA1</scp>, <scp>GABRB2</scp>, <scp>GABRB3</scp>, <scp>GABRG2</scp></i>): A cohort study, review of literature, and genotype–phenotype correlation

|Epilepsia|2022|80

Challenges and new perspectives of developmental cognitive EEG studies

|NeuroImage|2022|49